How Much Did Canton Allergy Raise?
Funding & Key Investors

Canton Allergy has secured $93K in total investment, with a recent capital infusion of $93K designated for substantial expansion. This financing round, occurring on January 27, 2021, signifies a critical growth phase for the company, likely aligning with a Series B or C stage of development, underscoring its strategic trajectory in the healthcare sector.

The company's latest funding event, a debt financing of $93M, highlights its ability to leverage financial instruments for operational scaling and market penetration.

What is Canton Allergy?

Canton Allergy
Hospitals & Physicians ClinicsPhysicians ClinicsMedical Practice Management

Canton Allergy is a specialized healthcare provider focused on delivering expert pediatric and adult care for individuals experiencing allergies, asthma, and immunological conditions within Michigan. Under the leadership of Dr. Steven V. Stryk, the clinic offers a comprehensive suite of services, including in-depth evaluations, precise diagnostic testing, and tailored treatment strategies designed to optimize patient outcomes. The practice emphasizes a compassionate and family-centric approach, establishing itself as a reliable resource for patients across all age demographics. Their medical interventions encompass allergy immunotherapy (allergy shots), prescription pharmaceuticals, and a variety of diagnostic procedures aimed at effectively managing and treating a broad spectrum of health issues.

How much funding has Canton Allergy raised?

Canton Allergy has raised a total of $93K across 1 funding round:

2021

Debt

$93K

Debt (2021): $93K with participation from PPP

Key Investors in Canton Allergy

PPP

Public-Private Partnership

What's next for Canton Allergy?

With the recent substantial expansion capital, Canton Allergy is poised for significant growth and enhanced service delivery. The strategic investment is expected to fuel initiatives such as expanding clinic locations, upgrading diagnostic and treatment technologies, and potentially broadening the scope of specialized care offered. This infusion of financing will likely enable the company to reach a wider patient base, further solidify its market position in Michigan, and continue its mission of providing high-quality, compassionate care for allergy, asthma, and immunological conditions. The company's focus on patient well-being and advanced treatment protocols positions it for sustained success in the competitive healthcare landscape.

See full Canton Allergy company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Hospitals & Physicians Clinics industry

Hospitals & Physicians ClinicsMedical Practice ManagementDental Practice ManagementPhysicians Clinics
Hospitals & Physicians ClinicsPhysicians Clinics
Hospitals & Physicians ClinicsMedical & Surgical Hospitals
Hospitals & Physicians ClinicsMedical Practice ManagementConsumer ServicesSpa and Salon Management

Frequently Asked Questions Regarding Canton Allergy Financial Insights

What are the most recent funding rounds that Canton Allergy has completed, and what were the funding rounds?
Canton Allergy has recently completed 1 funding rounds: Debt on Jan 27, 2021.
What is the total amount of funding Canton Allergy has raised to date?
Canton Allergy has raised a total of $93K in funding to date.
How many funding rounds has Canton Allergy completed?
Canton Allergy has completed 1 funding rounds.
How much funding did Canton Allergy raise in its most recent funding round?
Canton Allergy raised $93K in its most recent funding round.
Who are the lead investors in Canton Allergy's latest funding round?
The lead investor in Canton Allergy's latest funding round was PPP. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Canton Allergy's history?
The largest funding round in Canton Allergy's history was $93K.
See more information about Canton Allergy